Enrollment of the first group of participants in a Phase 3 clinical trial testing obudanersen in people with Angelman syndrome is complete, with 136 children taking part in the study to determine whether the treatment can improve communication. The REVEAL study (NCT06914609) will evaluate the therapy in kids and adults.
Discussion
It was the day before a long weekend, and we were supposed to leave that afternoon for a family road trip we’d planned six months earlier. Six hours in Jude’s life in April 2026, clockwise from top left: Jude tries on glasses in the morning, is wheeled away in…
Discussion
Oak Hill Bio has secured $32.5 million in financing to advance rugonersen, an experimental treatment for Angelman syndrome once in the pipeline at Roche, into late-stage clinical testing. The planned Phase 3 trial was dubbed pivotal by the developer in a company press release, which called rugonersen…
Becoming educated and informed about Angelman syndrome is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your Angelman syndrome journey.
There is no cure for Angelman syndrome yet, but there are treatments that can help manage the disease. Learn more about the approved and experimental therapies here.
Get regular updates to your inbox.
